Home Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A
 

Keywords :   


Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A

2013-02-06 10:00:00| drugdiscoveryonline Home Page

Seattle Genetics, Inc. recently announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas

Tags: phase seattle trials genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
01.07Tropical Storm Chris Public Advisory Number 2A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
01.07Tropical Storm Chris Update Statement
More »